Skip to main content
Publications
Ilomaki J, Bell JS, Chan EW, Tolppanen A-M, Luo H, Wei L, Lai EC, Shin J-U, De Paoli G, Pajouheshnia R, Ho FK, Reynolds L, Lau KK, Crystal S, Lau WCY, Man KKC, Brauer R, Chan AYL, Shen C-Y, Kim JH, Lum TYS, Hartikainen S, Koponen M, Rooke E, Bazelier M, Klungel O, Setoguchi S, Pell JP, Cook S, Wong ICK. Application of healthcare 'big data' in CNS drug research: the example of the neurological and mental health global epidemiology network (NeuroGEN). CNS Drugs. 2020 Sep;34(9):897-913. doi: 10.1007/s40263-020-00742-4
Elmasry MA, Sampani K, Abdelal OM, Fleming A, Souka A, Elbaha S, Silva PS, Sun JK, Aiello LP. Disparity of microaneurysm count between ultrawide field color imaging (UWF-CI) and ultrawide field fluorescein angiography (UWF-FA) in eyes with diabetic retinopathy. Poster presented at the ARVO Annual Meeting; May 3, 2020. Baltimore, MD. [abstract] Invest Ophth Vis Sci. 2020 Jun; 61(7):5306.
Silva PS, Cavallerano J, Elmasry MA, Fleming A, van Hemert J, Lewis D, Bhaskar V, Tolson A, Tolls D, Sun JK, Aiello LP. Impact of visible retinal area on diabetic retinopathy severity and detection of predominantly peripheral lesions when using ultrawide field imaging. Poster presented at the ARVO Annual Meeting; May 3, 2020. Baltimore, MD. [abstract] Invest Ophth Vis Sci. 2020 Jun 1; 61(7):3201.
Shokrollahi S, Elmasry MA, Sampani K, Pisig AU, Abdelal O, Robertson G, Fleming A, Pitoc CM, Sun JK, Silva PS, Aiello LP. Association of ultrawide field (UWF) retinal vessel caliber with diabetic retinopathy (DR) severity, predominantly peripheral lesions (PPL) and retinal nonperfusion (NP). Poster presented at the 2019 ARVO Annual Meeting; April 28, 2019. Vancouver, Canada. [abstract] Invest Ophth Vis Sci. 2019 Jul 1; 60(9):4771.
Silva PS, Stanton RC, Elmasry MA, Fleming A, Pellegrini E, van Hemert J, Tolls D, Tolson AM, Lewis D, Stainback J, Cavallerano JD, Sun JK, Aiello LP. Association of systemic comorbities with predominantly peripheral diabetic retinopathy lesions (PPL) identified on ultrawide field (UWF) retinal imaging. Poster presented at the 2019 ARVO Annual Meeting; April 28, 2019. Vancouver, Canada. [abstract] Invest Ophth Vis Sci. 2019 Jul 1; 60(9):4772.
Pladevall-Vila M, Pottegard A, Schink T, Reutfors J, Morros R, Poblador-Plou B, Timmer A, Forns J, Hellfritzsch M, Reinders T, Hagg D, Giner-Soriano M, Prados-Torres A, Cainzos-Achirica M, Hallas J, Brandt L, Cortes J, Aguado J, Perlemuter G, Falissard B, Castellsague J, Jacquot E, Deltour N, Perez-Gutthann S. Risk of acute liver injury in agomelatine and other antidepressant users in four European countries: a cohort and nested case-control study using automated health data sources. CNS Drugs. 2019 Apr;33(4):383-95. doi: 10.1007/s40263-019-00611-9
Pisig AU, Sampani K, Elmasry MA, Aldairy Y, Robertson G, Fleming A, Pitoc C, Rhee J, Sun JK, Silva PS, Aiello LP. Regional vessel caliber, retinal oximetry and predominantly peripheral diabetic retinal lesions as surrogate markers of nonperfusion on ultrawide field angiography in diabetic eyes. Poster presented at the 2018 ARVO Annual Meeting; April 29, 2018. Honolulu, HI. [abstract] Invest Ophth Vis Sci. 2018 Jul 1; 59(9):3448.
Sears CM, Hirano T, Nittala MG, Mehta NS, Sinha S, Jayadev C, Singh G, Verhoek M, Fleming A, van Hmert J, Tsui I, Prasad P, Sadda SR. Ethnic variation in diabetic retinopathy lesion distribution. Poster presented at the 2018 ARVO Annual Meeting; April 29, 2018. Honolulu, HI. [abstract] Invest Ophth Vis Sci. 2018 Jul 1; 59(9):4681.